MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 27.12.2025
AnPac Bio-Medical Science Co., Ltd. Abschreibung & Amortisation 2011-2026 | ANPC
Abschreibung & Amortisation Jährlich AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.7 M | 3.91 M | 3.1 M | 2.66 M | 3.14 M | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.7 M | 2.66 M | 3.5 M |
Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 0.89 | - | $ 6.54 M | China |
 |
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.2 | - | $ 3.68 B |  USA |
 |
Edesa Biotech
EDSA
|
186 K | $ 15.9 | - | $ 50.8 M | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Exelixis
EXEL
|
29.1 M | $ 44.69 | - | $ 12.1 B | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Harmony Biosciences Holdings
HRMY
|
23.8 M | $ 31.05 | - | $ 1.79 B | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | USA |
 |
ImmuCell Corporation
ICCC
|
2.78 M | $ 8.44 | - | $ 76.2 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
199 K | - | -2.5 % | $ 5.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
Incyte Corporation
INCY
|
93.3 M | $ 99.1 | - | $ 19.3 B | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
InMed Pharmaceuticals
INM
|
202 K | $ 0.7 | - | $ 1.71 M | Canada |
 |
INmune Bio
INMB
|
84 K | $ 1.33 | - | $ 32.9 M | USA |
 |
Innoviva
INVA
|
26.3 M | $ 23.05 | - | $ 1.55 B | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Jaguar Health
JAGX
|
1.91 M | $ 7.88 | - | $ 18.4 M | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
969 K | $ 26.67 | - | $ 1.44 B |  Britain |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 2.98 | - | $ 4.91 M |  Israel |
 |
Krystal Biotech
KRYS
|
5.72 M | $ 259.95 | - | $ 7.52 B | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
35.2 M | $ 224.86 | - | $ 4.11 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Liquidia Corporation
LQDA
|
1.53 M | $ 38.15 | - | $ 3.28 B | USA |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aquestive Therapeutics
AQST
|
548 K | $ 4.05 | - | $ 433 M | USA |
 |
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | USA |